Display options
Cite
Gera M, Sharma N, Ghosh M, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget. 2017;8(39):66680-66698doi: 10.18632/oncotarget.19164.
Gera, M., Sharma, N., Ghosh, M., Huynh, D. L., Lee, S. J., Min, T., Kwon, T., & Jeong, D. K. (2017). Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget, 8(39), 66680-66698. https://doi.org/10.18632/oncotarget.19164
Gera, Meeta, et al. "Nanoformulations of curcumin: an emerging paradigm for improved remedial application." Oncotarget vol. 8,39 (2017): 66680-66698. doi: https://doi.org/10.18632/oncotarget.19164
Gera M, Sharma N, Ghosh M, Huynh DL, Lee SJ, Min T, Kwon T, Jeong DK. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget. 2017 Jul 11;8(39):66680-66698. doi: 10.18632/oncotarget.19164. eCollection 2017 Sep 12. PMID: 29029547; PMCID: PMC5630447.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Jul 11;8(39):66680-66698. doi: 10.18632/oncotarget.19164. eCollection 2017 Sep 12.

Nanoformulations of curcumin: an emerging paradigm for improved remedial application.

Oncotarget

Meeta Gera, Neelesh Sharma, Mrinmoy Ghosh, Do Luong Huynh, Sung Jin Lee, Taesun Min, Taeho Kwon, Dong Kee Jeong

Affiliations

  1. Department of Animal Biotechnology, Faculty of Biotechnology, Jeju National University, Jeju, Republic of Korea.
  2. Division of Veterinary Medicine, Faculty of Veterinary Science and Animal Husbandry, Sher-e-Kashmi University of Agricultural Sciences and Technology, R.S. Pura, Jammu, India.
  3. Department of Animal Biotechnology, College of Animal Bioscience and Technology, Kangwon National University, Gangwon-do, Republic of Korea.
  4. Laboratory of Animal Genetic Engineering and Stem Cell Biology, Subtropical/Tropical Organism Gene Bank, Jeju National University, Jeju, Republic of Korea.

PMID: 29029547 PMCID: PMC5630447 DOI: 10.18632/oncotarget.19164

Abstract

Curcumin is a natural polyphenol and essential curcuminoid derived from the rhizome of the medicinal plant

Keywords: curcumin; herb; nano; nanoformulation; nanotechnology

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interests.

References

  1. Nat Nanotechnol. 2007 Apr;2(4):249-55 - PubMed
  2. ACS Appl Mater Interfaces. 2015 May 6;7(17 ):9235-46 - PubMed
  3. Adv Pharm Bull. 2016 Mar;6(1):17-21 - PubMed
  4. Anticancer Res. 2009 Oct;29(10):3867-75 - PubMed
  5. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Dec;25(12):1140-4 - PubMed
  6. Biochem Pharmacol. 2010 Oct 1;80(7):1021-32 - PubMed
  7. Int J Pharm. 2012 Nov 1;437(1-2):110-9 - PubMed
  8. Sci Rep. 2016 Feb 03;6:20051 - PubMed
  9. Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8 - PubMed
  10. Nanoscale. 2011 Apr;3(4):1558-67 - PubMed
  11. Nat Prod Commun. 2010 Dec;5(12):1935-8 - PubMed
  12. Clin Pharmacokinet. 2010 Jul;49(7):449-54 - PubMed
  13. Nano Lett. 2006 Apr;6(4):662-8 - PubMed
  14. J Am Acad Dermatol. 2008 Apr;58(4):625-31 - PubMed
  15. FEBS Lett. 1999 Feb 19;445(1):165-8 - PubMed
  16. Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):651-4 - PubMed
  17. Pharm Res. 2008 Aug;25(8):1815-21 - PubMed
  18. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5204-9 - PubMed
  19. J Oleo Sci. 2015 ;64(1):27-40 - PubMed
  20. Cancer Res. 2001 Feb 1;61(3):1058-64 - PubMed
  21. Molecules. 2015 Feb 05;20(2):2728-69 - PubMed
  22. J Nanobiotechnology. 2014 Feb 03;12:5 - PubMed
  23. J Cell Mol Med. 2010 Apr;14(4):970-81 - PubMed
  24. Nutr Cancer. 2010;62(8):1137-41 - PubMed
  25. BMC Complement Altern Med. 2006 Mar 17;6:10 - PubMed
  26. BMC Complement Altern Med. 2016 Aug 20;16(1):299 - PubMed
  27. Eur J Pharm Biopharm. 2010 Nov;76(3):475-85 - PubMed
  28. Nanoscale Res Lett. 2015 Dec;10(1):381 - PubMed
  29. Food Funct. 2011 Jul;2(7):373-80 - PubMed
  30. Nanoscale. 2012 Jan 7;4(1):239-50 - PubMed
  31. Int J Nanomedicine. 2011;6:2779-90 - PubMed
  32. Nutr Cancer. 2014;66(6):1015-22 - PubMed
  33. Biochem Pharmacol. 1996 Aug 23;52(4):519-25 - PubMed
  34. Cancer Lett. 2005 Jun 8;223(2):181-90 - PubMed
  35. Toxicol Lett. 2007 Jan 30;168(2):121-31 - PubMed
  36. J Nanobiotechnology. 2007 Apr 17;5:3 - PubMed
  37. Mol Cancer. 2011 Feb 07;10:12 - PubMed
  38. J Nanosci Nanotechnol. 2011 Aug;11(8):6642-56 - PubMed
  39. Anticancer Res. 2001 Jul-Aug;21(4B):2895-900 - PubMed
  40. Biomatter. 2012 Oct-Dec;2(4):296-312 - PubMed
  41. Mol Pharm. 2011 Jun 6;8(3):852-66 - PubMed
  42. J Agric Food Chem. 2006 Feb 8;54(3):756-64 - PubMed
  43. J Colloid Interface Sci. 2010 Nov 1;351(1):19-29 - PubMed
  44. Mol Pharm. 2009 May-Jun;6(3):928-39 - PubMed
  45. Toxicol Lett. 2008 Oct 1;181(3):182-9 - PubMed
  46. Int J Food Microbiol. 2009 Nov 30;136(1):71-4 - PubMed
  47. Nat Chem Biol. 2007 Jul;3(7):360-6 - PubMed
  48. J Oncol Pharm Pract. 2012 Jun;18(2):186-90 - PubMed
  49. Tumour Biol. 2014 Aug;35(8):7295-305 - PubMed
  50. J Alzheimers Dis. 2011;23(1):61-77 - PubMed
  51. Int J Pharm. 2010 Oct 15;398(1-2):190-203 - PubMed
  52. Cancer Biol Ther. 2010 Jan;9(1):8-14 - PubMed
  53. Biophys J. 2001 Apr;80(4):1733-43 - PubMed
  54. Oxid Med Cell Longev. 2013;2013:801418 - PubMed
  55. J Clin Invest. 2008 Mar;118(3):879-93 - PubMed
  56. Cancer Res Treat. 2014 Jan;46(1):2-18 - PubMed
  57. Clin Cancer Res. 2007 Jun 1;13(11):3423-30 - PubMed
  58. Mol Pharm. 2007 Nov-Dec;4(6):807-18 - PubMed
  59. Endoscopy. 2004 Jul;36(7):609-11 - PubMed
  60. Int J Pharm. 2015 Dec 30;496(2):732-40 - PubMed
  61. Free Radic Biol Med. 2003 Dec 15;35(12):1632-44 - PubMed
  62. Nutr Cancer. 2010;62(7):919-30 - PubMed
  63. Cancer Lett. 2008 Oct 8;269(2):199-225 - PubMed
  64. Z Lebensm Unters Forsch. 1985 May;180(5):402-4 - PubMed
  65. Drug Des Devel Ther. 2016 Aug 17;10 :2643-9 - PubMed
  66. J Pharm Sci. 2010 Apr;99(4):1871-81 - PubMed
  67. Chem Pharm Bull (Tokyo). 2011;59(2):172-8 - PubMed
  68. Antimicrob Agents Chemother. 2009 Apr;53(4):1592-7 - PubMed
  69. ACS Nano. 2014 Jan 28;8(1):76-103 - PubMed
  70. Biochim Biophys Acta. 1994 Nov 10;1224(2):255-63 - PubMed
  71. Cancer Invest. 2011 Mar;29(3):208-13 - PubMed
  72. Biochem Pharmacol. 2012 Jan 1;83(1):6-15 - PubMed
  73. FEBS Lett. 2010 Feb 19;584(4):707-12 - PubMed
  74. Mol Pharm. 2008 Jul-Aug;5(4):505-15 - PubMed
  75. Med Res Rev. 2012 Jul;32(4):687-726 - PubMed
  76. Arch Pharm (Weinheim). 2010 Sep;343(9):489-99 - PubMed
  77. Mol Nutr Food Res. 2013 Sep;57(9):1529-42 - PubMed
  78. Altern Med Rev. 2009 Jun;14 (2):141-53 - PubMed
  79. J Biol Chem. 1995 Oct 20;270(42):24995-5000 - PubMed
  80. Cancer Res. 2008 Jul 1;68(13):5345-54 - PubMed
  81. Cell Mol Life Sci. 2008 Jun;65(11):1631-52 - PubMed
  82. Biosci Rep. 2010 Dec;30(6):391-404 - PubMed
  83. Drug Metab Dispos. 1999 Apr;27(4):486-94 - PubMed
  84. Clin Cancer Res. 2011 Sep 15;17(18):5953-61 - PubMed
  85. Int J Nanomedicine. 2009;4:115-22 - PubMed
  86. Acta Biomater. 2012 Jul;8(7):2670-87 - PubMed
  87. J Phys Chem B. 2010 Aug 5;114(30):9778-86 - PubMed
  88. J Alzheimers Dis. 2012;30(2):377-92 - PubMed
  89. Invest New Drugs. 2015 Dec;33(6):1175-86 - PubMed
  90. J Cell Biochem. 2010 May 15;110(2):447-56 - PubMed
  91. Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3270-5 - PubMed
  92. Crit Rev Food Sci Nutr. 2017 Nov 2;57(16):3449-3463 - PubMed
  93. Zhong Yao Cai. 2010 May;33(5):797-801 - PubMed
  94. J Clin Invest. 2008 Mar;118(3):868-78 - PubMed
  95. J Complement Integr Med. 2013 Jul 01;10:null - PubMed
  96. J Pharm Pharmacol. 2000 Sep;52(9):1123-8 - PubMed
  97. Free Radic Res. 2004 Apr;38(4):355-62 - PubMed
  98. Colloids Surf B Biointerfaces. 2017 Aug 1;156:254-261 - PubMed
  99. Biomaterials. 2005 May;26(13):1565-73 - PubMed
  100. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):105-11 - PubMed
  101. J Control Release. 2010 Nov 1;147(3):408-12 - PubMed
  102. Neurosci Lett. 2017 Jun 9;651:226-231 - PubMed
  103. Clin Cancer Res. 2008 Oct 1;14(19):6228-36 - PubMed
  104. Mol Pharm. 2010 Jun 7;7(3):815-25 - PubMed
  105. J Agric Food Chem. 1999 Oct;47(10 ):4297-300 - PubMed
  106. Xenobiotica. 1978 Dec;8(12):761-8 - PubMed
  107. Appl Biochem Biotechnol. 2015 Jun;176(3):712-29 - PubMed
  108. Acta Pharmacol Toxicol (Copenh). 1978 Aug;43(2):86-92 - PubMed
  109. Curr Pharm Des. 2009;15(18):2087-94 - PubMed
  110. Int J Biochem Cell Biol. 2009 Jan;41(1):40-59 - PubMed
  111. Nutr Cancer. 2012;64(7):975-81 - PubMed
  112. Int J Pharm. 2005 Jul 25;298(2):315-22 - PubMed
  113. J Soc Integr Oncol. 2007 Winter;5(1):25-37 - PubMed
  114. Carcinogenesis. 2015 Mar;36(3):355-67 - PubMed
  115. Biochem J. 2008 Feb 15;410(1):147-55 - PubMed
  116. AAPS J. 2013 Jan;15(1):195-218 - PubMed
  117. J Agric Food Chem. 2009 Jan 14;57(1):305-10 - PubMed
  118. Arzneimittelforschung. 1996 Feb;46(2):169-71 - PubMed
  119. Biol Pharm Bull. 2011;34(5):660-5 - PubMed
  120. Int J Oncol. 2008 May;32(5):1119-23 - PubMed
  121. Nat Rev Drug Discov. 2010 Aug;9(8):615-27 - PubMed
  122. Toxicology. 1981-1982;22(4):337-44 - PubMed
  123. J Biol Chem. 2010 Aug 13;285(33):25332-44 - PubMed
  124. Biomaterials. 2011 Mar;32(7):1890-905 - PubMed
  125. J Pharm Pharmacol. 1973 Jun;25(6):447-52 - PubMed
  126. PLoS One. 2015 Mar 26;10(3):e0121313 - PubMed
  127. Nanomedicine. 2010 Feb;6(1):153-60 - PubMed
  128. Int J Nanomedicine. 2012;7:151-62 - PubMed
  129. Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):248-58 - PubMed
  130. APMIS. 1999 Jan;107(1):128-36 - PubMed
  131. Ann N Y Acad Sci. 2001 Dec;953:3-25 - PubMed
  132. Planta Med. 2017 Mar;83(5):434-444 - PubMed
  133. Cancer Lett. 1995 Aug 16;95(1-2):221-5 - PubMed
  134. Biomaterials. 2014 Jan;35(3):1074-88 - PubMed

Publication Types